kabutan

Fuji Pharma Co.,Ltd.(4554) Summary

4554
TSE Prime
Fuji Pharma Co.,Ltd.
2,225
JPY
-7
(-0.31%)
Mar 13, 3:30 pm JST
13.95
USD
Mar 13, 2:30 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
24.3
PBR
1.14
Yield
2.11%
Margin Trading Ratio
20.40
Stock Price
Mar 13, 2026
Opening Mar 13, 9:00 am
2,190 JPY 13.75 USD
Previous Close Mar 12
2,232 JPY 14.04 USD
High Mar 13, 10:32 am
2,257 JPY 14.18 USD
Low Mar 13, 9:00 am
2,190 JPY 13.75 USD
Volume
87,500
Trading Value
0.20B JPY 1.22M USD
VWAP
2226.38 JPY 13.97 USD
Minimum Trading Value
222,500 JPY 1,395 USD
Market Cap
0.06T JPY 0.35B USD
Number of Trades
355
Liquidity & Number of Trades
As of Mar 13, 2026
Liquidity
Mid
1-Year Average
381
1-Year High Feb 6, 2026
4,337
Margin Trading
Date Short Interest Long Margin Positions Ratio
Mar 6, 2026 30,200 443,200 14.68
Feb 27, 2026 98,000 395,700 4.04
Feb 20, 2026 100,600 352,300 3.50
Feb 13, 2026 81,800 346,400 4.23
Feb 6, 2026 90,700 349,200 3.85
Company Profile
Fuji Pharma Co., Ltd. is a leading generic pharmaceutical company, specializing in fertility treatments and contrast agents. The company is also expanding into new drugs and biosimilars.
Sector
Pharmaceuticals
Fuji Pharma Co., Ltd. is a major generic drug manufacturer, primarily focusing on injectable products such as hormone preparations for obstetrics and gynecology, and urinary tract and vascular contrast agents for radiology. The company operates through five branch offices nationwide, engaging in the development, manufacturing, and sales of pharmaceuticals. With one consolidated subsidiary, Fuji Pharma conducts product trading and financial lending with its Thai subsidiary. Operating under a single pharmaceutical business segment, the company offers a diverse product lineup to meet a wide range of medical needs. As a pharmaceutical manufacturer with particular strengths in obstetrics, gynecology, and radiology, Fuji Pharma Co., Ltd. conducts business both domestically and internationally.